Page last updated: 2024-08-23

buserelin and tamoxifen

buserelin has been researched along with tamoxifen in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	17 (38.64)	18.7374
1990's	20 (45.45)	18.2507
2000's	7 (15.91)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, W; Gold, E; Goulding, A	1
Baird, DT; Lumsden, MA; West, CP	1
Aakvaag, A; Johannessen, DC; Lien, EA; Lønning, PE	1
Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF	1
Broux, R; Corhay, JL; Limet, R; Radermecker, M	1
Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC	1
Blamey, RW; Dixon, AR; Jackson, L; Nicholson, RI; Robertson, JF	1
Tattersall, MH; Wilcken, N	1
Blamey, RW; Bouzubar, N; Dixon, AR; Ellis, IO; McClelland, R; Nicholson, RI; Robertson, JF; Walker, KJ	1
Gateley, CA; Mansel, RE	1
Forsling, ML; Kelestimur, H; Windle, R	1
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR	2
Bouzubar, N; Davies, P; Gee, JM; Nicholson, RI; Rushmere, NK; Walker, KJ; Wills, RJ	1
Distler, W; von Matthiessen, H	1
Eidtmann, H; Jonat, W; Kügler, G; Kunz, T; Maass, H	1
Coyle, J; Fisher, B; Gunduz, N; Rudock, C; Saffer, E	2
Blamey, RW; Dixon, A; McClelland, RA; Nicholson, RI; Robertson, JF; Walker, KJ	1
Blamey, RW; Griffiths, K; Nicholson, RI; Robertson, JF; Turkes, A; Walker, KJ; Walker, RF	1
Hartmann, A; Mann, K	1
Cantwell, BM; Carmichael, J; Dowsett, M; Harris, AL	1
Bakker, GH; De Jong, FH; Foekens, JA; Klijn, JG; Portengen, H; Setyono-Han, B	1
Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA	1
Baird, DT; Hillier, H; Lumsden, MA; West, CP	1
Blamey, RW; Nicholson, RI; Robertson, JF; Walker, KJ	2
Cheson, BD	1
Harvey, H; Lipton, A; Manni, A; Max, D; Santen, R	1
Blankenstein, MA; Foekens, JA; Fukkink, JF; Henkelman, MS; Klijn, JG	1
Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW	1
Blankenstein, MA; Henkelman, MS; Klijn, JG	1
Hall, JM; Whitehead, SA	1
Alexieva-Figusch, J; Blankenstein, MA; Blonk-van der Wijst, J; de Jong, FH; Docter, R; Klijn, JG; Lamberts, SW	1
Klijn, JG	1
Gold, E; Goulding, A; Stapley, S	1
Black, CM; Jacobs, HS; Ostlere, LS; Rustin, MH; Stevens, HP	1
Davidson, NE	1
Becquart, D; Beex, LV; Burghouts, J; Duchateau, L; Jassem, J; Klijn, JG; Mauriac, L; Mignolet, F; Piccart, M; Seynaeve, C; van Zijl, JA; Veyret, C; Wildiers, J	1
Powles, TJ	1
Blamey, RW; Boccardo, F; Duchateau, L; Klijn, JG; Sylvester, R; Tominaga, T	1
Illiger, HJ; Willeke, K	1
Noguchi, S; Taguchi, T	1
Boĭko, AV; Bychkova, NM; Dar'ialova, SL; Novikova, OV	1

Reviews

5 review(s) available for buserelin and tamoxifen

Article	Year
Goserelin (Zoladex) in the treatment of fibroids. British journal of obstetrics and gynaecology, 1992, Volume: 99 Suppl 7 Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms	1992
Endocrine therapy for desmoid tumors. Cancer, 1991, Sep-15, Volume: 68, Issue:6 Topics: Adult; Buserelin; Female; Fibroma; Goserelin; Humans; Intestinal Neoplasms; Intestine, Small; Leg; Tamoxifen	1991
New trends in the endocrine treatment of breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1990
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-15, Volume: 19, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Premenopause; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen	2001
[Clinical applications of GnRHa in breast cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 4 Topics: Breast Neoplasms; Buserelin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Ovariectomy; Randomized Controlled Trials as Topic; Tamoxifen	2006

Trials

7 trial(s) available for buserelin and tamoxifen

Article	Year
Primary systemic therapy for operable breast cancer. British journal of cancer, 1991, Volume: 63, Issue:4 Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen	1991
New trends in the endocrine treatment of breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1990
Zoladex plus tamoxifen versus Zoladex alone in pre- and peri-menopausal metastatic breast cancer. The Journal of steroid biochemistry and molecular biology, 1990, Dec-20, Volume: 37, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cell Transformation, Neoplastic; Female; Freezing; Goserelin; Humans; Immunoenzyme Techniques; Middle Aged; Receptors, Estrogen; Remission Induction; Solubility; Tamoxifen	1990
LHRH-agonist treatment in clinical and experimental human breast cancer. Journal of steroid biochemistry, 1985, Volume: 23, Issue:5B Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen	1985
Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer. Breast cancer research and treatment, 1984, Volume: 4, Issue:3 Topics: Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen	1984
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. Journal of the National Cancer Institute, 2000, Jun-07, Volume: 92, Issue:11 Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Disease-Free Survival; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Menstrual Cycle; Middle Aged; Premenopause; Prognosis; Prospective Studies; Risk Factors; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome	2000
[Combination therapy with buserelin and tamoxifen in metastatic breast cancer in premenopause: a randomized study]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Disease Progression; Disease-Free Survival; Female; Humans; Premenopause; Tamoxifen; Time Factors	2001

Other Studies

33 other study(ies) available for buserelin and tamoxifen

Article	Year
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin. Bone and mineral, 1992, Volume: 18, Issue:2 Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Disease Models, Animal; Drug Interactions; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Organ Size; Rats; Rats, Inbred Strains; Tamoxifen; Uterus	1992
Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 41, Issue:3-8 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cortisone; Female; Goserelin; Humans; Insulin-Like Growth Factor I; Menopause; Middle Aged; Tamoxifen	1992
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer. British journal of cancer, 1992, Volume: 65, Issue:5 Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen	1992
Failure of buserelin-induced medical castration to control pulmonary lymphangiomyomatosis in two patients. Chest, 1992, Volume: 101, Issue:6 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Evaluation; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pneumothorax; Recurrence; Tamoxifen	1992
Combined goserelin and tamoxifen in premenopausal advanced breast cancer: duration of response and survival. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Middle Aged; Tamoxifen	1991
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:7 Topics: Antibodies, Monoclonal; Breast Neoplasms; Buserelin; Cell Division; Female; Goserelin; Humans; Immunohistochemistry; Menopause; Predictive Value of Tests; Receptors, Estrogen; Tamoxifen	1991
Management of the painful and nodular breast. British medical bulletin, 1991, Volume: 47, Issue:2 Topics: Adult; Age Factors; Breast Diseases; Bromocriptine; Buserelin; Danazol; Estrogen Replacement Therapy; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Goserelin; Humans; Hypolipidemic Agents; Linoleic Acids; Oenothera biennis; Pain; Plant Oils; Tamoxifen	1991
The influence of reproductive status on vasopressin release in the rat. The Journal of endocrinology, 1991, Volume: 130, Issue:3 Topics: Animals; Buserelin; Estrus; Female; Goserelin; Osmolar Concentration; Ovariectomy; Ovary; Pituitary Gland; Rats; Rats, Inbred Strains; Tamoxifen; Vasopressins; Water-Electrolyte Balance	1991
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. British journal of cancer, 1990, Volume: 61, Issue:1 Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen	1990
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1990, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen	1990
Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects. Annals of the New York Academy of Sciences, 1990, Volume: 595 Topics: Breast Neoplasms; Buserelin; Estradiol; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Menopause; Polyunsaturated Alkamides; Tamoxifen	1990
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen	1990
Serum growth factor following primary tumor removal and the inhibition of its production by preoperative therapy. Progress in clinical and biological research, 1990, Volume: 354A Topics: Animals; Buserelin; Combined Modality Therapy; Culture Media; Cyclophosphamide; Female; Goserelin; Growth Substances; In Vitro Techniques; Mice; Neoplasms, Experimental; Preoperative Care; Tamoxifen; Tritium	1990
Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer research, 1989, Apr-15, Volume: 49, Issue:8 Topics: Animals; Buserelin; Combined Modality Therapy; Cyclophosphamide; DNA; Female; Goserelin; Growth Substances; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Tamoxifen	1989
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Progesterone; Tamoxifen	1989
[Therapy with LHRH analogs in a 41-year-old patient with metastatic breast cancer]. Der Internist, 1989, Volume: 30, Issue:4 Topics: Adenocarcinoma; Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Femoral Neoplasms; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Male; Tamoxifen; Triptorelin Pamoate	1989
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer. British journal of cancer, 1989, Volume: 59, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged; Tamoxifen	1989
Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors. Endocrinology, 1989, Volume: 125, Issue:3 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cytosol; Drug Implants; Estrenes; Female; Follicle Stimulating Hormone; Goserelin; Injections, Subcutaneous; Luteinizing Hormone; Mammary Neoplasms, Experimental; Mifepristone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1989
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. British journal of cancer, 1989, Volume: 60, Issue:2 Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen	1989
Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids. Fertility and sterility, 1989, Volume: 52, Issue:6 Topics: Amenorrhea; Buserelin; Creatinine; Drug Therapy, Combination; Estradiol; Estrogens; Female; Fibrosis; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Progesterone; Tamoxifen; Uterine Diseases	1989
Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancer. The British journal of surgery, 1989, Volume: 76, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Middle Aged; Tamoxifen	1989
Zoladex in advanced breast cancer. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Goserelin; Humans; Ovary; Tamoxifen	1989
Clinical trials referral resource. Adjuvant therapy of breast cancer. Oncology (Williston Park, N.Y.), 1989, Volume: 3, Issue:6 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen	1989
Treatment of breast cancer with gonadotropin-releasing hormone. Endocrine reviews, 1986, Volume: 7, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Tamoxifen	1986
Combined effects of buserelin, estradiol and tamoxifen on the growth of MCF-7 human breast cancer cells in vitro. Biochemical and biophysical research communications, 1986, Oct-30, Volume: 140, Issue:2 Topics: Breast Neoplasms; Buserelin; Cell Division; Cell Nucleus; Cytosol; Estradiol; Humans; In Vitro Techniques; Neoplasm Proteins; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Stem Cell Assay	1986
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells. European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:12 Topics: Breast Neoplasms; Buserelin; Cell Division; Cell Line; Culture Media; DNA, Neoplasm; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Neoplasm Proteins; Tamoxifen	1985
Effects of chronic treatment with oestrogen, an oestrogen antagonist and a potent luteinizing hormone releasing hormone agonist analogue on pituitary responsiveness to luteinizing hormone releasing hormone in the rat. The Journal of endocrinology, 1983, Volume: 98, Issue:3 Topics: Animals; Buserelin; Castration; Drug Implants; Estradiol; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Pituitary Gland; Rats; Rats, Inbred Strains; Tamoxifen	1983
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments. Medical oncology and tumor pharmacotherapy, 1984, Volume: 1, Issue:2 Topics: Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen	1984
Tamoxifen and norethisterone: effects on plasma cholesterol and total body calcium content in the estrogen-deficient rat. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1994, Volume: 26, Issue:2 Topics: Animals; Bone Diseases, Metabolic; Buserelin; Calcium; Cholesterol; Estradiol; Estrogens; Female; Norethindrone; Rats; Tamoxifen	1994
Cyclical psoriatic arthritis responding to anti-oestrogen therapy. The British journal of dermatology, 1993, Volume: 129, Issue:4 Topics: Adult; Arthritis, Psoriatic; Buserelin; Endometrium; Estradiol; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menstruation; Psoriasis; Tamoxifen; Ultrasonography	1993
Combined endocrine therapy for breast cancer--new life for an old idea? Journal of the National Cancer Institute, 2000, Jun-07, Volume: 92, Issue:11 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Confounding Factors, Epidemiologic; Disease-Free Survival; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ovary; Premenopause; Randomized Controlled Trials as Topic; Research Design; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome	2000
Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. Journal of the National Cancer Institute, 2000, Dec-20, Volume: 92, Issue:24 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Premenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Research Design; Tamoxifen; Treatment Outcome	2000
[The enigma of desmoid fibroma]. Voprosy onkologii, 2006, Volume: 52, Issue:4 Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Agents, Hormonal; Buserelin; Child; Child, Preschool; Female; Fibroma, Desmoplastic; Fibromatosis, Aggressive; Follow-Up Studies; Goserelin; Humans; Infant; Male; Middle Aged; Tamoxifen; Treatment Outcome	2006